Page 62 of JBH's annual report:
- Cash - $49m
- Trade receivables - $81m
- Trade liabilities -$325m
Stating the obvious JBH being a market leader can negotiate and trade on more favourable terms so can afford much larger liabilities on their books.
As long as SHP can meet demand with supply, get paid by customers quicker than paying their suppliers, generate positive operating cashflow, then it shouldn't need to raise funds.
- Forums
- ASX - By Stock
- Ann: Appendix 4E - Preliminary Final Report
Page 62 of JBH's annual report: - Cash - $49m - Trade...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HT8 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
-0.001(10.0%) |
Mkt cap ! $2.991M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $18 | 2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 129110 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 86166 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43542 | 0.011 |
2 | 285040 | 0.010 |
4 | 391000 | 0.009 |
2 | 525000 | 0.008 |
2 | 230000 | 0.007 |
Price($) | Vol. | No. |
---|---|---|
0.012 | 1722119 | 3 |
0.013 | 1772868 | 6 |
0.014 | 60000 | 1 |
0.015 | 735762 | 4 |
0.017 | 780001 | 1 |
Last trade - 10.04am 25/11/2024 (20 minute delay) ? |
Featured News
HT8 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online